TNFRSF11B and peripheral arterial disease: Several trials have reported higher OPG plasma levels in patients with coronary artery disease (CAD), peripheral artery disease (PAD), chronic heart failure (CHF), and atrial fibrillation, suggesting the association between OPG and CVD (11,12,13,14,15,16).